NIR-Triggered Thermosensitive Nanoreactors for Dual-Guard Mechanism-Mediated Precise and Controllable Cancer Chemo-Phototherapy
Biomacromolecules · 2024
DOI: 10.1021/acs.biomac.3c01070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2024. Verfasst von Guoxi Qiu und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Science, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China. Hauptthemen laut MEDLINE: Hyperthermia, Induced, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Science, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.
ORCID-Profile: Hong Yuan, Fuqiang Hu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Qiu, G., Zhou, W., Liu, Y., Meng, T., Yu, F., Jin, X., Lian, K., Zhou, X., Yuan, H., & Hu, F. (2024). NIR-Triggered Thermosensitive Nanoreactors for Dual-Guard Mechanism-Mediated Precise and Controllable Cancer Chemo-Phototherapy. Biomacromolecules. https://doi.org/10.1021/acs.biomac.3c01070
Vancouver
Qiu G, Zhou W, Liu Y, Meng T, Yu F, Jin X, et al. NIR-Triggered Thermosensitive Nanoreactors for Dual-Guard Mechanism-Mediated Precise and Controllable Cancer Chemo-Phototherapy. Biomacromolecules. 2024. doi:10.1021/acs.biomac.3c01070
BibTeX
@article{Qiu2024,
author = {Qiu, Guoxi and Zhou, Wentao and Liu, Yupeng and Meng, Tingting and Yu, Fangying and Jin, Xiangyu and Lian, Keke and Zhou, Xueqing and Yuan, Hong and Hu, Fuqiang},
title = {NIR-Triggered Thermosensitive Nanoreactors for Dual-Guard Mechanism-Mediated Precise and Controllable Cancer Chemo-Phototherapy},
journal = {Biomacromolecules},
year = {2024},
doi = {10.1021/acs.biomac.3c01070}
}
EUVIMED